Dupixent 300 mg solution for injection in pre-filled syringe clinical trials
6 indexed studies · 0 currently recruiting
- Ongoing, recruitingPhase II and Phase III (Integrated)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients with Bullous Pemphigoid
This study is testing a new medicine, Dupixent, for a skin condition called Bullous Pemphigoid. We want to see if it helps heal the skin and reduce itching better than current treatments, looking at how safe and effective it is for adults.
For: Bullous PemphigoidFrance · Poland · Germany - Ongoing, recruitingTherapeutic use (Phase IV)
A phase IV, randomized double blinded placebo-controlled study on the barrier restoring capacity of Dupilumab in type 2 airway disease: CRSwNP
This study is looking at how a medicine called Dupixent (Dupilumab) might help people with long-term stuffy nose and growths called nasal polyps. We want to see if it helps fix the natural barrier in the nose lining.
For: chronic rhinosinusitis with nasal polypsBelgium - Ongoing, recruitingTherapeutic use (Phase IV)
Effect of Dupilumab on nasal epithelial barrier function in patients with Chronic Rhinosinusitis with nasal polyps (CRSwNP) – an exploratory pilot study
This study looks at how a medicine called Dupixent affects the lining of the nose in people with long-term sinus problems and polyps. It aims to see if the medicine helps strengthen this lining and reduce their symptoms.
For: Chronic rhinosinusitis with nasal polyps · Chronic rhinosinusitis without nasal polypsAustria - Ongoing, recruitingTherapeutic exploratory (Phase II)
An investigator-initiated, multi-center, randomized, double-blind, placebo controlled study of Dupilumab to demonstrate efficacy in subjects with nummular eczema
This study is looking into a new treatment called Dupilumab (Dupixent) for people with a type of eczema called nummular eczema. Researchers want to see if it makes their skin better and improves their quality of life. It's an important step in finding new ways to help manage this skin condition.
For: Subjects with nummular eczemaGermany - Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo- and Active-controlled, Dose ranging Study to Evaluate the Efficacy and Safety of JNJ-95475939 for the Treatment of Participants with Moderate to Severe Atopic Dermatitis
This study is testing a new medicine, JNJ-95475939, for adults who have moderate to severe eczema (atopic dermatitis). Researchers want to see if it helps improve skin symptoms compared to a dummy medicine or an existing treatment called Dupixent.
For: Moderate to Severe Atopic DermatitisSpain · Poland · Germany - AuthorisedTherapeutic use (Phase IV)
Long-term effect of Dupilumab on acetylsalicylic acid (ASA) intolerance and its mechanisms in patients with non-steroidal anti-inflammatory drug-exacerbated respiratory disease (N-ERD)
This study looks at how a medicine called Dupixent (Dupilumab) might help people with a condition called N-ERD to tolerate aspirin better. Researchers will compare how much aspirin people can take before and after 6 months of Dupixent treatment.
For: non-steroidal anti-inflammatory drug-exacerbated respiratory disease (N-ERD)Austria